摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Nona-3,6-dienyl 4-methylbenzenesulfonate

中文名称
——
中文别名
——
英文名称
Nona-3,6-dienyl 4-methylbenzenesulfonate
英文别名
nona-3,6-dienyl 4-methylbenzenesulfonate
Nona-3,6-dienyl 4-methylbenzenesulfonate化学式
CAS
——
化学式
C16H22O3S
mdl
——
分子量
294.4
InChiKey
MZYCRMXDQHZTBX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    20
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Anti-cancer nitro- and thia-fatty acids
    申请人:——
    公开号:US20030078299A1
    公开(公告)日:2003-04-24
    The present invention relates to pharmaceutical compositions comprising, as an anti-cancer agent: (a) one or more compounds having the formula NO 2 —A—B, 1 wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 double bonds, and B is (CH 2 ) m (COOH) n in which n is a integer from 0 to 2 and m is an integer from 0 to 2; or a derivative thereof in which the hydrocarbon chain has one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy; (b) one or more compounds selected from polyunsaturated fatty acids (PUFA's) having a 16 to 26 carbon atom chain and 3 to 16 double bonds, and wherein the PUFA is covalently coupled at the carboxylic acid group to an amino acid selected from glycine and aspartic acid; (c) one or more compounds selected from unsaturated fatty acids having an 18 to 25 carbon atom chain and 1 to 6 double bonds and wherein the fatty acid has one or two &bgr;-oxa, &ggr;-oxa, &bgr;-thia, &ggr;-thia substitutions: or (d) one or more compounds having formula (I) wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH 2 ) J (COOH) k in which j is an integer from 1 to 3 and K is 0 or 1; or a derivative thereof in which the hydrocarbon chain has one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy; and a pharmaceutically acceptable carrier or diluent.
    本发明涉及制药组合物,包括作为抗癌剂的:(a) 一个或多个具有式NO2—A—B,1的化合物,其中A是14-26个双键的饱和或不饱和碳氢链,B是(CH2)m(COOH)n,其中n是0到2的整数,m是0到2的整数;或其衍生物,其中碳氢链具有羟基、过氧化氢基、环氧基和过氧基中的一种或多种取代;(b) 一种或多种选择自具有16到26个碳原子链和3到16个双键的多不饱和脂肪酸(PUFA),其中PUFA在羧酸基上与选择自甘酸和天冬氨酸氨基酸共价耦合;(c) 一种或多种选择自具有18到25个碳原子链和1到6个双键的不饱和脂肪酸,其中脂肪酸具有一或两个β-氧杂、γ-氧杂、β-杂、γ-杂取代;或(d) 公式(I)中A′是9-26个碳原子的饱和或不饱和碳氢链,X是氧或不存在,B′是( )J(COOH)k,其中j是1到3的整数,k是0或1;或其衍生物,其中碳氢链具有羟基、过氧化氢基、环氧基和过氧基中的一种或多种取代;以及药学上可接受的载体或稀释剂。
  • HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS
    申请人:Miller Raymond A.
    公开号:US20110082206A1
    公开(公告)日:2011-04-07
    Activated fatty acids, pharmaceutical compositions including activated fatty acids, methods for using activated fatty acids to treat a variety of diseases, and methods for preparing activated fatty acids are provided herein.
    本文提供了活化脂肪酸、包括活化脂肪酸的制药组合物、使用活化脂肪酸治疗各种疾病的方法以及制备活化脂肪酸的方法。
  • Anti-inflammatory nitro and thia-fatty acids
    申请人:——
    公开号:US20030092762A1
    公开(公告)日:2003-05-15
    The present invention relates to compounds of the general formula: NO 2 -A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH 2 ) n (COOH) m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH 2 ) j (COOH) k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
    本发明涉及一般式为:NO2-A-B的化合物,其中A是14-26个碳原子的饱和或不饱和碳氢链,B是(CH2)n(COOH)min,其中n是0到2的整数,m是0到2的整数;或一般式(I)的化合物,其中A′是9-26个碳原子的饱和或不饱和碳氢链,X是氧或不存在,B′是( )j(COOH)kin,其中j是1到3的整数,k是0或1;以及其衍生物,其中碳氢链包括一个或多个羟基,过氧化氢基,环氧基和过氧基的取代。这些化合物具有生物活性,例如作为抗感染或抗炎剂。
  • Anti-inflammatory nitro-and thia-fatty acids
    申请人:Ferrante Antonio
    公开号:US20050176815A1
    公开(公告)日:2005-08-11
    The present invention relates to compounds of the general formula: NO 2 -A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH 2 ) n (COOH) m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH 2 ) j (COOH) k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
    本发明涉及一般式为NO2-A-B的化合物,其中A是14-26个碳原子的饱和或不饱和碳氢链,B是(CH2)n(COOH)min,其中n为0到2的整数,m为0到2的整数;或者一般式(I)中,A'是9-26个碳原子的饱和或不饱和碳氢链,X为氧或不存在,B'为( )j(COOH)kin,其中j为1到3的整数,k为0或1;以及其衍生物,其中碳氢链包括一个或多个羟基、羟过氧基、环氧基和过氧基的取代。这些化合物具有生物活性,例如作为抗感染或抗炎剂。
  • Anti-inflammatory nitro- and thia-fatty acids
    申请人:Ferrante Antonio
    公开号:US20050176816A1
    公开(公告)日:2005-08-11
    The present invention relates to compounds of the general formula: NO 2 -A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH 2 ) n (COOH) m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH 2 ) j (COOH) k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
    本发明涉及一般式为NO2-A-B的化合物,其中A是14-26个碳原子的饱和或不饱和碳氢链,B是(CH2)n(COOH)min,其中n为0到2的整数,m为0到2的整数;或一般式(I)中,A'是9-26个碳原子的饱和或不饱和碳氢链,X是氧或不存在,B'是( )j(COOH)kin,其中j为1到3的整数,k为0或1;以及其中烃链包括一种或多种羟基,羟过氧化物,环氧和过氧化物等取代基的衍生物。这些化合物具有生物活性,例如作为抗感染或抗炎剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫